Surteco Group SE

Surteco Group SE has a debt-to-equity ratio of 1.16 and a current ratio of 0.92, indicating moderate leverage and liquidity constraints. The company reported negative net income of EUR -14.34 million and operating income of EUR 13.72 million, with a return on equity of -3.94% and return on assets of -1.51%. These metrics suggest that the company is underperforming relative to its capital base and is not generating sufficient returns to cover its costs of capital. The company's profitability is further constrained by its operating cash flow of EUR 48.81 million and free cash flow of EUR 9.59 million, which are insufficient to cover its capital expenditures of EUR -29.77 million. This indicates that the company is reinvesting in its operations but is not generating enough cash to sustain these investments without external financing. Geographically, Surteco Group SE is heavily concentrated in the European market, with no disclosed revenue breakdown by region. This concentration exposes the company to regional economic fluctuations and regulatory changes, which could impact its revenue stability and growth potential. Looking ahead, the company is expected to face challenges in maintaining its revenue and profitability. The outlook for the current fiscal year is uncertain, with no clear direction provided. The company's capital expenditures are expected to remain a significant portion of its operating cash flow, which could limit its ability to invest in growth opportunities or return capital to shareholders. The risk assessment for Surteco Group SE highlights medium liquidity risk and low dilution risk. The company's net cash position is negative after subtracting total debt, which could lead to liquidity constraints if cash flow does not improve. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, which is a positive sign for shareholders. Recent events and filings indicate that the company is focused on managing its liquidity and improving its financial performance. The company has not disclosed any major strategic initiatives or new product launches in the latest filings. Analysts have provided a mean price target of EUR 20.20, with a mean recommendation of 2.00, indicating a neutral stance on the stock.